WallStSmart
ATHE

Alterity Therapeutics Ltd

NASDAQ: ATHE · HEALTHCARE · BIOTECHNOLOGY

$1.96
+0.00% today

Updated 2026-11-16

Market cap
$37.42M
P/E ratio
—
P/S ratio
10.37x
EPS (TTM)
$-0.85
Dividend yield
—
52W range
$2 – $6
Volume
0.1M

Alterity Therapeutics Ltd (ATHE) Financial Forecast & Price Target 2030

Revenue-driven projection model with historical context.

Price target summary

Current price
$1.96
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—

Financial forecast

Metric20222023202420252026
Revenue$0.0B$0.0B$0.0B$0.0B$0.0B
EPS—————
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 0.00%

Methodology

CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.